Trial · NCT02125461
Adverse events354
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 354
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Durvalumab (MEDI4736) | 35 | 475 | 39 |
| other | Anaemia | Blood and lymphatic system disorders | Placebo | 26 | 234 | 32 |
| other | Hyperthyroidism | Endocrine disorders | Durvalumab (MEDI4736) | 35 | 475 | 39 |
| other | Hyperthyroidism | Endocrine disorders | Placebo | 4 | 234 | 4 |
| other | Hypothyroidism | Endocrine disorders | Durvalumab (MEDI4736) | 54 | 475 | 62 |
| other | Hypothyroidism | Endocrine disorders | Placebo | 4 | 234 | 4 |
| other | Constipation | Gastrointestinal disorders | Durvalumab (MEDI4736) | 57 | 475 | 59 |
| other | Constipation | Gastrointestinal disorders | Placebo | 20 | 234 | 27 |
| other | Diarrhoea | Gastrointestinal disorders | Durvalumab (MEDI4736) | 87 | 475 | 136 |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 46 | 234 | 56 |
| other | Vomiting | Gastrointestinal disorders | Durvalumab (MEDI4736) | 36 | 475 | 45 |
| other | Vomiting | Gastrointestinal disorders | Placebo | 19 | 234 | 25 |
| other | Upper respiratory tract infection | Infections and infestations | Durvalumab (MEDI4736) | 57 | 475 | 69 |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 24 | 234 | 30 |
| other | Nausea | Gastrointestinal disorders | Durvalumab (MEDI4736) | 68 | 475 | 88 |
| other | Nausea | Gastrointestinal disorders | Placebo | 31 | 234 | 43 |
| other | Asthenia | General disorders | Durvalumab (MEDI4736) | 51 | 475 | 73 |
| other | Asthenia | General disorders | Placebo | 31 | 234 | 50 |
| other | Fatigue | General disorders | Durvalumab (MEDI4736) | 114 | 475 | 130 |
| other | Fatigue | General disorders | Placebo | 47 | 234 | 52 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02125461/events